A β1/2 adrenergic receptor-sensitive intracellular signaling pathway modulates CCL2 production in cultured spinal astrocytes

Journal of Cellular Physiology

Volumn 229, Issue 3, 2014, Pages 323-332

  Morioka, Norimitsu ^a   Abe, Hiromi ^a   Araki, Ryosuke ^a   Matsumoto, Naoki ^a   Zhang, Fan Fan ^a   Nakamura, Yoki ^a   Hisaoka Nakashima, Kazue ^a   Nakata, Yoshihiro ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCL2; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLYCOGEN SYNTHASE KINASE 3BETA; ISOPRENALINE; MESSENGER RNA; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; INTRACELLULAR SIGNALING; NERVOUS SYSTEM INFLAMMATION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REAL TIME POLYMERASE CHAIN REACTION;

ADRENERGIC AGONISTS; ADRENERGIC ANTAGONISTS; ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; CELLS, CULTURED; CHEMOKINE CCL2; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; GLYCOGEN SYNTHASE KINASE 3; INFLAMMATION MEDIATORS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2; SIGNAL TRANSDUCTION; SPINAL CORD; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84888032935     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24452     Document Type: Article

References (43)

1. Abbadie C, Lindia JA, Cumiskey AM, Peterson LB, Mudgett JS, Bayne EK, DeMartino JA, MacIntyre DE, Forrest MJ. 2003. Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc Natl Acad Sci USA 100:7947-7952.
2. Abbadie C, Bhangoo S, De Koninck Y, Malcangio M, Melik-Parsadaniantz S, White FA. 2009. Chemokines and pain mechanisms. Brain Res Rev 60:125-134.
3. Ahmed RA, Murao K, Imachi H, Yoshida K, Dobashi H, Hosomi N, Ishida T. 2009. c-Jun N-terminal kinases inhibitor suppresses the TNF-alpha induced MCP-1 expression in human umbilical vein endothelial cells. Endocrine 35:184-188.
4. Allen NJ, Barres BA. 2009. Neuroscience: Glia-More than just brain glue. Nature 457:675-677.
5. Cassina P, Pehar M, Vargas MR, Castellanos R, Barbeito AG, Estévez AG, Thompson JA, Beckman JS, Barbeito L. 2005. Astrocyte activation by fibroblast growth factor-1 and motor neuron apoptosis: Implications for amyotrophic lateral sclerosis. J Neurochem 93:38-46.
6. Choucair-Jaafar N, Yalcin I, Rodeau JL, Waltisperger E, Freund-Mercier MJ, Barrot M. 2009. Beta2-adrenoceptor agonists alleviate neuropathic allodynia in mice after chronic treatment. Br J Pharmacol 158:1683-1694.
7. Christiansen SH, Selige J, Dunkern T, Rassov A, Leist M. 2011. Combined anti-inflammatory effects of β2-adrenergic agonists and PDE4 inhibitors on astrocytes by upregulation of intracellular cAMP. Neurochem Int 59:837-846.
8. De Keyser J, Zeinstra E, Wilczak N. 2004. Astrocytic beta2-adrenergic receptors and multiple sclerosis. Neurobiol Dis 15:331-339.
9. Gao YJ, Ji RR. 2010. Light touch induces ERK activation in superficial dorsal horn neurons after inflammation: Involvement of spinal astrocytes and JNK signaling in touch-evoked central sensitization and mechanical allodynia. J Neurochem 115:505-514.
10. Gao YJ, Zhang L, Samad OA, Suter MR, Yasuhiko K, Xu ZZ, Park JY, Lind AL, Ma Q, Ji RR. 2009. JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain. J Neurosci 29:4096-4108.
11. Gao YJ, Xu ZZ, Liu YC, Wen YR, Decosterd I, Ji RR. 2010a. The c-Jun N-terminal kinase 1 (JNK1) in spinal astrocytes is required for the maintenance of bilateral mechanical allodynia under a persistent inflammatory pain condition. Pain 148:309-319.
12. Gao YJ, Zhang L, Ji RR. 2010b. Spinal injection of TNF-α-activated astrocytes produces persistent pain symptom mechanical allodynia by releasing monocyte chemoattractant protein-1. Glia 58:1871-1880.
13. Gavrilyuk V, Dello Russo C, Heneka MT, Pelligrino D, Weinberg G, Feinstein DL. 2002. Norepinephrine increases I kappa B alpha expression in astrocytes. J Biol Chem 277:29662-29668.
14. Giraud SN, Caron CM, Pham-Dinh D, Kitabgi P, Nicot AB. 2010. Estradiol inhibits ongoing autoimmune neuroinflammation and NFkappaB-dependent CCL2 expression in reactive astrocytes. Proc Natl Acad Sci USA 107:8416-8421.
15. Hartz AM, Madole EK, Miller DS, Bauer B. 2010. Estrogen receptor beta signaling through phosphatase and tensin homolog/phosphoinositide 3-kinase/Akt/glycogen synthase kinase 3 down-regulates blood-brain barrier breast cancer resistance protein. J Pharmacol Exp Ther 334:467-476.
16. Heneka MT, Galea E, Gavriluyk V, Dumitrescu-Ozimek L, Daeschner J, O'Banion MK, Weinberg G, Klockgether T, Feinstein DL. 2002. Noradrenergic depletion potentiates beta-amyloid-induced cortical inflammation: Implications for Alzheimer's disease. J Neurosci 22:2434-2442.
17. Hsiao HY, Mak OT, Yang CS, Liu YP, Fang KM, Tzeng SF. 2007. TNF-alpha/IFN-gamma-induced iNOS expression increased by prostaglandin E2 in rat primary astrocytes via EP2-evoked cAMP/PKA and intracellular calcium signaling. Glia 55:214-223.
18. Ji RR, Kawasaki Y, Zhuang ZY, Wen YR, Decosterd I. 2006. Possible role of spinal astrocytes in maintaining chronic pain sensitization: Review of current evidence with focus on bFGF/JNK pathway. Neuron Glia Biol 2:259-269.
19. Johnson JD, Zimomra ZR, Stewart LT. 2013. Beta-adrenergic receptor activation primes microglia cytokine production. J Neuroimmunol 254:161-164.
20. Jope RS, Johnson GV. 2004. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci 29:95-102.
21. Koga S, Kojima S, Kishimoto T, Kuwabara S, Yamaguchi A. 2012. Over-expression of map kinase phosphatase-1 (MKP-1) suppresses neuronal death through regulating JNK signaling in hypoxia/re-oxygenation. Brain Res 1436:137-146.
22. Lepore AC, O'Donnell J, Kim AS, Yang EJ, Tuteja A, Haidet-Phillips A, O'Banion CP, Maragakis NJ. 2011. Reduction in expression of the astrocyte glutamate transporter, GLT1, worsens functional and histological outcomes following traumatic spinal cord injury. Glia 59:1996-2005.
23. Morioka N, Tanabe H, Inoue A, Dohi T, Nakata Y. 2009. Noradrenaline reduces the ATP-stimulated phosphorylation of p38 MAP kinase via beta-adrenergic receptors-cAMP-protein kinase A-dependent mechanism in cultured rat spinal microglia. Neurochem Int 55:226-234.
24. Morioka N, Sugimoto T, Tokuhara M, Nakamura Y, Abe H, Hisaoka K, Dohi T, Nakata Y. 2012. Spinal astrocytes contribute to the circadian oscillation of glutamine synthase, cyclooxygenase-1 and clock genes in the lumbar spinal cord of mice. Neurochem Int 60:817-826.
25. Nakagawa T, Kaneko S. 2010. Spinal astrocytes as therapeutic targets for pathological pain. J Pharmacol Sci 114:347-353.
26. Ousman SS, David S. 2001. MIP-1alpha, MCP-1, GM-CSF, and TNF-alpha control the immune cell response that mediates rapid phagocytosis of myelin from the adult mouse spinal cord. J Neurosci 21:4649-4656.
27. Park CH, Moon Y, Shin CM, Chung JH. 2010. Cyclic AMP suppresses matrix metalloproteinase-1 expression through inhibition of MAPK and GSK-3beta. J Invest Dermatol 130:2049-2056.
28. Parpura V, Heneka MT, Montana V, Oliet SH, Schousboe A, Haydon PG, Stout RF, Spray DC, Reichenbach A, Pannicke T, Pekny M, Pekna M, Zorec R, Verkhratsky A. 2012. Glial cells in (patho)physiology. J Neurochem 121:4-27.
29. Pocock JM, Kettenmann H. 2007. Neurotransmitter receptors on microglia. Trends Neurosci 30:527-535.
30. Price DM, Chik CL, Ho AK. 2004a. Norepinephrine induction of mitogen-activated protein kinase phosphatase-1 expression in rat pinealocytes: Distinct roles of alpha- and beta-adrenergic receptors. Endocrinology 145:5723-5733.
31. Price DM, Chik CL, Terriff D, Weller J, Humphries A, Carter DA, Klein DC, Ho AK. 2004b. Mitogen-activated protein kinase phosphatase-1 (MKP-1): >100-fold nocturnal and norepinephrine-induced changes in the rat pineal gland. FEBS Lett 577:220-226.
32. Price DM, Wloka MT, Chik CL, Ho AK. 2007. Mitogen-activated protein kinase phosphatase-1 (MKP-1) preferentially dephosphorylates p42/44MAPK but not p38MAPK in rat pinealocytes. J Neurochem 101:1685-1693.
33. Rostène W, Dansereau MA, Godefroy D, Van Steenwinckel J, Reaux-Le Goazigo A, Mélik-Parsadaniantz S, Apartis E, Hunot S, Beaudet N, Sarret P. 2011. Neurochemokines: A menage a trois providing new insights on the functions of chemokines in the central nervous system. J Neurochem 118:680-694.
34. Sewer MB, Waterman MR. 2003. CAMP-dependent protein kinase enhances CYP17 transcription via MKP-1 activation in H295R human adrenocortical cells. J Biol Chem 278:8106-8111.
35. Staples CJ, Owens DM, Maier JV, Cato AC, Keyse SM. 2010. Cross-talk between the p38alpha and JNK MAPK pathways mediated by MAP kinase phosphatase-1 determines cellular sensitivity to UV radiation. J Biol Chem 285:25928-25940.
36. Sugimoto T, Morioka N, Sato K, Hisaoka K, Nakata Y. 2011. Noradrenergic regulation of period1 expression in spinal astrocytes is involved in protein kinase A, c-Jun N-terminal kinase and extracellular signal-regulated kinase activation mediated by α1- and β2-adrenoceptors. Neuroscience 185:1-13.
37. Taurin S, Hogarth K, Sandbo N, Yau DM, Dulin NO. 2007. Gbetagamma-mediated prostacyclin production and cAMP-dependent protein kinase activation by endothelin-1 promotes vascular smooth muscle cell hypertrophy through inhibition of glycogen synthase kinase-3. J Biol Chem 282:19518-19525.
38. Tokuhara N, Namiki K, Uesugi M, Miyamoto C, Ohgoh M, Ido K, Yoshinaga T, Yamauchi T, Kuromitsu J, Kimura S, Miyamoto N, Kasuya Y. 2010. N-type calcium channel in the pathogenesis of experimental autoimmune encephalomyelitis. J Biol Chem 285:33294-33306.
39. Van Steenwinckel J, Reaux-Le Goazigo A, Pommier B, Mauborgne A, Dansereau MA, Kitabgi PA, Sarret P, Pohl M, Mélik Parsadaniantz S. 2011. CCL2 released from neuronal synaptic vesicles in the spinal cord is a major mediator of local inflammation and pain after peripheral nerve injury. J Neurosci 31:5865-5875.
40. Waetzig V, Czeloth K, Hidding U, Mielke K, Kanzow M, Brecht S, Goetz M, Lucius R, Herdegen T, Hanisch UK. 2005. c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia. Glia 50:235-246.
41. Wang MJ, Huang HY, Chen WF, Chang HF, Kuo JS. 2010. Glycogen synthase kinase-3β inactivation inhibits tumor necrosis factor-α production in microglia by modulating nuclear factor κB and MLK3/JNK signaling cascades. J Neuroinflammation 7:99.
42. Zhang Z, Wang Z, Ren H, Yue M, Huang K, Gu H, Liu M, Du B, Qian M. 2011. P2Y(6) agonist uridine 5′-diphosphate promotes host defense against bacterial infection via monocyte chemoattractant protein-1-mediated monocytes/macrophages recruitment. J Immunol 186:5376-5387.
43. Zhuang ZY, Wen YR, Zhang DR, Borsello T, Bonny C, Strichartz GR, Decosterd I, Ji RR. 2006. A peptide c-Jun N-terminal kinase (JNK) inhibitor blocks mechanical allodynia after spinal nerve ligation: Respective roles of JNK activation in primary sensory neurons and spinal astrocytes for neuropathic pain development and maintenance. J Neurosci 26:3551-3560.